Patent details

Basic Information

Publication number:

EP3567042

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP191641265

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CDK INHIBITORS

French Title of Invention:

INHIBITEURS DE CDK

German Title of Invention:

CDK-HEMMER

SPC Number:

Dates

Filing date:

25/10/2011

Grant date:

07/07/2021

EP Publication Date:

13/11/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/07/2021

EP B1 Publication Date:

07/07/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/10/2021

Expiration date:

25/10/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/06/2021

 

 

Name:

G1 Therapeutics, Inc.

Address:

700 Park Offices Drive, Suite 200, Research Triangle Park, NC 27709, United States (US)

Inventor

1

Name:

STRUM, Jay C.

Address:

United States (US)

2

Name:

TAVARES, Francis, X.

Address:

United States (US)

Priority

Priority Number:

40649810 P

Priority Date:

25/10/2010

Priority Country:

United States (US)

Classification

IPC classification:

C07D 487/14; C07D 487/20; C07D 519/00; A61K 31/519; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202127

Publication date:

07/07/2021

Description:

Grant (B1)

2

Issue number:

202132

Publication date:

11/08/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages